Little Known Facts About ABBV-744 as a potential therapeutic option for aggressive cancers.
In combination with These clinical trials described above, there have also been pre-clinical studies that confirmed excellent performance with regards to equally safety and effectiveness from AML.There might be increased treatment burden for members On this trial when compared with their normal of treatment. Participants will attend common visits i